Match tier
Listed
Presence
Current · Arkansas
Last published
2019
Sources
OpenAlex · ORCID
Refreshed
2026-10-03
S
Sherrica Tai
Role not yet determined Is this you? Add your title
Also affiliated: Northeastern University (2011–2015); University of Michigan (2016–2018); University of Arkansas Medical Center (2014–2015); Michigan Medicine (2017–2018)
8 h-index
18 pubs
533 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Sherrica Tai's research has focused on understanding health disparities and their impact on various populations. Her work has explored the intersection of social determinants of health and patient outcomes, with an emphasis on vulnerable communities. Tai has contributed to the literature by examining factors that contribute to differential health outcomes and by investigating potential interventions to mitigate these disparities.
Metrics
- h-index: 8
- Publications: 18
- Citations: 533
Selected Publications
-
Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein–Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ9-Tetrahydrocannabinol and JWH-018 (2019)
-
Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice (2018)
-
Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development (2017)
-
Synthetic Pot: Not Your Grandfather’s Marijuana (2017)
-
Novel Synthetic Cannabinoid AB‐PINACA Produces THC‐Like Behavioral and Cellular Effects Through activation of the Cannabinoid CB1 Receptor (2016)
-
Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites (2016)
-
Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist (2015)
-
Convulsant effects of high efficacy synthetic cannabinoid JWH‐018 in mice (2015)
-
Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential (2014)
Collaboration Network
Top Collaborators
William E. Fantegrossi
University of Arkansas for Medical Sciences
8 shared publications
In database
- Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential
- Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites
- Synthetic Pot: Not Your Grandfather’s Marijuana
- Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development
- Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice
Showing 5 of 8 shared publications
Paul L. Prather
University of Arkansas for Medical Sciences
4 shared publications
In database
- Synthetic Pot: Not Your Grandfather’s Marijuana
- Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development
- Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein–Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ9-Tetrahydrocannabinol and JWH-018
- Novel Synthetic Cannabinoid AB‐PINACA Produces THC‐Like Behavioral and Cellular Effects Through activation of the Cannabinoid CB1 Receptor
Benjamin M. Ford
University of Arkansas for Medical Sciences (US)
2 shared publications
- Synthetic Pot: Not Your Grandfather’s Marijuana
- Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development
Lirit N. Franks
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development
- Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein–Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ9-Tetrahydrocannabinol and JWH-018
Christian V. Cabanlong
University of Arkansas for Medical Sciences (US)
2 shared publications
- Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development
- Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein–Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ9-Tetrahydrocannabinol and JWH-018
Catheryn D. Wilson
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development
- Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice
Narsimha Reddy Penthala
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development
- Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein–Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ9-Tetrahydrocannabinol and JWH-018
Peter Anthony Crooks
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development
- Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein–Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ9-Tetrahydrocannabinol and JWH-018
Jasmine Crane
Middlebury College
2 shared publications
In database
- Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice
- Novel Synthetic Cannabinoid AB‐PINACA Produces THC‐Like Behavioral and Cellular Effects Through activation of the Cannabinoid CB1 Receptor
Kiristen Camper
Spelman College (US)
1 shared publication
- Convulsant effects of high efficacy synthetic cannabinoid JWH‐018 in mice
Caitlin O. Caperton
University of Arkansas at Little Rock
1 shared publication
In database
- Convulsant effects of high efficacy synthetic cannabinoid JWH‐018 in mice
Spyros P. Nikas
Northeastern University (US)
1 shared publication
- Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist
Vidyanand G. Shukla
Northeastern University (US)
1 shared publication
- Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist
Kiran Vemuri
Northeastern University (US)
1 shared publication
- Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist
Alexandros Makriyannis
Northeastern University (US)
1 shared publication
- Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist
Similar Researchers
Based on overlapping research topics
Andrea Easom
University of Arkansas for Medical Sciences
Health Disparities and Outcomes
Health and Medical Research Impacts
Racial and Ethnic Identity Research
Kincaid, John
University of Arkansas for Medical Sciences
Health Disparities and Outcomes
Health and Medical Research Impacts
Racial and Ethnic Identity Research
Keneshia Bryant
University of Arkansas for Medical Sciences
Health Disparities and Outcomes
Health and Medical Research Impacts
Racial and Ethnic Identity Research
Bryan Ladell Burke
University of Arkansas for Medical Sciences
Health Disparities and Outcomes
Health and Medical Research Impacts
Racial and Ethnic Identity Research
Sean Unger
University of Arkansas at Little Rock
Health Disparities and Outcomes
Health and Medical Research Impacts
Prashanth Reddy Damalcheruvu
University of Arkansas for Medical Sciences
Health Disparities and Outcomes
Health and Medical Research Impacts